112 related articles for article (PubMed ID: 2532859)
1. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition.
Ganeshaguru K; Piga A; Latini L; Hoffbrand AV
Adv Exp Med Biol; 1989; 253B():251-8. PubMed ID: 2532859
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antibody response in the presence of partial adenosine deaminase inhibition.
Hoffman EA; Kopp WC; Moat AG
Proc Soc Exp Biol Med; 1990 May; 194(1):36-42. PubMed ID: 2139230
[TBL] [Abstract][Full Text] [Related]
5. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
Hayward AR
Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
[TBL] [Abstract][Full Text] [Related]
6. Niacin prevents DNA strand breakage by adenosine deaminase inhibitors.
Weitberg AB; Corvese D
Biochem Biophys Res Commun; 1990 Mar; 167(2):514-9. PubMed ID: 2322239
[TBL] [Abstract][Full Text] [Related]
7. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis.
Sims JL; Berger SJ; Berger NA
Biochemistry; 1983 Oct; 22(22):5188-94. PubMed ID: 6317018
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
[TBL] [Abstract][Full Text] [Related]
11. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
13. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
Seto S; Carrera CJ; Wasson DB; Carson DA
J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.
Schraufstatter IU; Hyslop PA; Hinshaw DB; Spragg RG; Sklar LA; Cochrane CG
Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4908-12. PubMed ID: 2941760
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
17. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
[No Abstract] [Full Text] [Related]
18. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphocyte-specific enzymes: a promising approach for selective immunosuppression.
Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
Transplant Proc; 1987 Feb; 19(1 Pt 2):1287-9. PubMed ID: 3274319
[No Abstract] [Full Text] [Related]
20. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
